Vaccinex
$4.109876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.32 (-7.24%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Vaccinex and other stocks, options, ETFs, and crypto commission-free!
About VCNX
Vaccinex, Inc. Common Stock, also called Vaccinex, is a clinical-stage biotechnology company, which engages in the development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Read More The firm focuses in the development of pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma and Huntington's disease. Its products pipeline includes SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.
Employees
49
Headquarters
Rochester, New York
Founded
1997
Market Cap
71.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.43K
High Today
$4.65
Low Today
$4.10
Open Price
$4.65
Volume
11.18K
52 Week High
$12.23
52 Week Low
$3.80
Collections
VCNX Earnings
-$1.62
-$1.08
-$0.54
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 13, Pre-Market